# US 2025/0375484 A1 · Vascular associated naturally pluripotent stem cell and method of isolation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375484 A1
- Document ID: US20250375484A1
- Status: Published application
- Kind: A1
- Application number: 19/067,665
- Filed: 2025-02-28
- Published: 2025-12-11
- Earliest claimed: 2021-09-03
- Assignees: SciCoTec GmbH
- Applicants: Scicotec GmbH
- Inventors: Eckhard U. ALT
- Web page: https://patentgrep.com/patent/US20250375484A1

## CPC

- A61K 35/545: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 35/44: Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
- A61K 35/51: Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A61P 19/04: for non-specific disorders of the connective tissue
- C12N 5/0667: {Adipose-derived stem cells [ADSC]; Adipose stromal stem cells}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A composition comprising isolated vascular-associated naturally pluripotent stem cells (vaPS), is disclosed, as well as method of treating defects using such composition, wherein said vaPS are capable of differentiating into somatic cells of all three germ layers under the guidance of the respective microenvironment.

## Claims

### Claim 1

A method of treating a defect in a mammalian subject, comprising:
a) isolating unmodified autologous vascular-associated pluripotent stem cells (UA-vaPS) from a mammalian subject;
b) introducing the UA-vaPS into the mammalian subject at or near the defect.

### Claim 2 (depends on 1)

The method of claim 1, wherein the UA-vaPS are isolated from a vascular tissue from the mammalian subject.

### Claim 3 (depends on 1)

The method of claim 1, wherein the UA-vaPS are isolated from an adipose-tissue from the mammalian subject.

### Claim 4 (depends on 1)

The method of claim 1, wherein the UA-vaPS are not cultured or expanded in vitro prior to step b).

### Claim 5 (depends on 1)

The method of claim 1, wherein the defect includes at least one of: tendon defects, cartilage defects, chronic, recalcitrant low back pain caused by lumbosacral facet syndrome, avascular necrosis of femoral head, wounds, scar tissues, and hair loss.
